Sign in
4

Changes in Ownership

4D Molecular Therapeutics, Inc. Filed Acc 0001567619-23-001163

Chief Executive Officer sold 19,524 shares at an average $20.10 ($392,474)

From the SEC's structured data for this filing

Trades in this filing

Kirn David · Chief Executive Officer

Table I: Non-derivative

2 lines
Date Transaction Shares Price Value Owned after D/I
2023-01-19 Sale : show line 1 in the form −10,899 $20.03 $218,347 1,902,224 D
2023-01-20 Sale : show line 2 in the form −8,625 $20.19 $174,127 1,893,599 D
Open-market sales · 19,524 sh · avg $20.10 · $392,474
Loading xslF345X03/doc1.xml…